- Approximately 19% of total revenue in 2025
- Achievements demonstrating competitiveness in the global medical device market
DRGEM, a global medical imaging solutions company, announced on the 22nd that it has signed a medical device supply contract worth 19.259 billion won with a Turkish company. The contract period runs from July 21, 2026, to December 20, 2026. The contract value represents 18.74% of the company’s total revenue for 2025.
DRGEM explained that this contract was secured through an intense international competitive bid. Furthermore, the company noted that winning the deal was the result of a comprehensive evaluation of its technological capabilities, product quality, brand credibility, competitive pricing, and reliable production and supply capabilities.
J. B. Park, CEO of DRGEM, stated, “This contract is a meaningful achievement won against major global players, driven by our technology, quality excellence, and customer trust.” He added, “Moving forward, we will continue to pursue research, development, and quality innovation.” He explained that this is based on DRGEM’s core values of ‘Quality, Value, Support’. As a result, DRGEM aims to deliver medical imaging diagnostic equipment that earns their customers’ trust.”
DRGEM is also accelerating efforts to strengthen its market edge and expand its global presence. The company’s new mobile X-ray system, “RAYMO,” received U.S. FDA 510(k) clearance in May and CE MDR certification in June of this year.
DRGEM plans to continue expanding its overseas footprint by leveraging product excellence that meets global standards alongside customer-centric services. Moreover, the company aims to strengthen the foundation for sustainable growth as a global leader in medical imaging solutions.
